ENVARSUS XR (tacrolimus extended-release) Patient Assistance Program
A missed dose of anti-rejection medication is not like missing any other pill — and cost should never be the reason it happens. Veloxis Transplant Support provides Envarsus XR free of charge to eligible patients — and we manage your entire enrollment for a flat $69.95 per month.
- Clear & Transparent Pricing — Applying To Veloxis Directly Is Always Free
- Paperwork, Documentation & Transplant-Team Coordination Handled For You
- Comprehensive Support: From Application To Entire Journey
- Medicare Part B vs Part D Guidance — Transplant Drugs Have Their Own Rules
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Envarsus XR (LCP-Tacrolimus) Is A Once-Daily Extended-Release Anti-Rejection Medication For Kidney Transplant Recipients — Engineered For Steadier Absorption Than Immediate-Release Tacrolimus, And By FDA Labeling It Is NOT Substitutable With Other Tacrolimus Products At The Pharmacy Counter.
- Cash Prices Run From About $168 To $860 Per 30 Tablets By Strength — And Because Daily Doses Often Require Multiple Tablets, Real Monthly Costs Can Exceed $2,000. No Generic Of The Envarsus Formulation Exists; Patents Run To 2028.
- The Veloxis Transplant Support Patient Assistance Program Provides Envarsus XR Free To Uninsured And Underinsured Patients — Including Federally Underinsured Medicare Patients — With A Bridge Program Covering Insurance Delays And A One-Time 30-Day Free Trial For New Patients.
- Medicare Rules Are Unique For Transplant Drugs: If Medicare Covered Your Transplant, Immunosuppressants Bill Under Part B (20% Coinsurance, No $2,100 Cap) — And Since 2023, Kidney Recipients Who Lose Medicare At 36 Months Can Keep Immunosuppressant-Only Part B Coverage For Life. Commercially Insured Patients Pay As Little As $0 With The Copay Card (Up To $9,200/Year).
What Is Envarsus XR Prescription Assistance Program?
The Envarsus XR Patient Assistance Program is run by Veloxis Transplant Support, the manufacturer’s dedicated patient hub, and provides Envarsus XR free of charge to qualifying uninsured and underinsured patients — notably including federally underinsured Medicare patients, a group most manufacturer programs exclude. Financial eligibility is verified annually and reviewed case by case, and enrollment authorizations run up to three years. Applying directly (1-844-VELOXIS / 1-844-835-6947) is always free. Transplant medication assistance has stakes no other category has: a coverage gap doesn’t mean symptoms, it means rejection risk. That’s why Veloxis also runs a Bridge Program (free medication during insurance delays for commercially insured patients) and a one-time 30-day free trial — and why the paperwork around Medicare’s transplant-specific billing rules matters so much. For a flat $69.95 per month, our Patient Advocates coordinate with your transplant team, keep every program current, and make sure there is never a month without medication.
Pharmacy Price Comparison
- Envarsus XR $500–$800/month. Generic tacrolimus IR much cheaper:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$780 | Save ~$710/mo |
| CVS Pharmacy | ~$800 | Save ~$730/mo |
| Walmart | ~$540 | Save ~$470/mo |
| Costco | ~$520 | Save ~$450/mo |
Generic tacrolimus IR | ~$25 | Already low (IR alt) |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Envarsus XR Prescription Program?
The Veloxis Transplant Support program is free to apply for and provides Envarsus XR at no medication cost if approved. Our $69.95/month service covers full advocacy — for transplant recipients who want an experienced team managing programs, renewals, and Medicare’s transplant-specific rules so a coverage gap never becomes a rejection risk.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Envarsus XR:
Limitations of Coupons
- Prices fluctuate — savings aren’t guaranteed month-to-month
- Copay accumulators may prevent savings from counting toward deductible
- Coupon cards expire and require constant renewal
Still $500–$800 per month even with the best discount
- Can’t be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
- Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
- Medication supplied directly through the assistance program
- We manage all paperwork, refills, and annual renewals
- If denied, we explore alternative savings on your behalf
DO YOU QUALIFY?
Veloxis Transplant Support reviews eligibility based on insurance status and financial need. You will generally qualify if the following are true — and if your situation doesn’t fit neatly, contact AffordMyPrescriptions so we can review your case and determine if you qualify for Envarsus XR assistance:
- You Are A U.S. Citizen Or Legal Resident
- You Have A Valid Envarsus XR Prescription From Your Transplant Team
- You Are Uninsured — Or Commercially Or Federally Underinsured, Including Medicare Patients With Coverage Gaps
- You Meet The Program’s Financial Eligibility Criteria (Verified Annually, Reviewed Case By Case)
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Understanding Envarsus XR:
Envarsus XR is tacrolimus — the backbone immunosuppressant of modern kidney transplantation — delivered through MeltDose (LCP) technology that releases the drug slowly and absorbs it more completely than immediate-release capsules.
How Envarsus XR Works:
Tacrolimus suppresses the immune signaling (calcineurin pathway) that would otherwise direct T-cells to attack a transplanted kidney. Its challenge has always been its narrow therapeutic window: too little risks rejection, too much causes toxicity, and blood levels swing with each dose. Envarsus XR’s extended-release formulation flattens those peaks and troughs, delivering steadier levels once daily — the clinical reason a transplant team chooses it over generic immediate-release tacrolimus, and the reason the two are not interchangeable.
Form and Use:
Once-daily tablets (0.75 mg, 1 mg, 4 mg) taken on an empty stomach at the same time each day; total daily dose is individualized to target blood levels your transplant team monitors regularly. Swallow whole — never cut, crush, or chew. Consistency is everything: this is a medication where the refill date is a clinical parameter, which is why every assistance program here is built around never missing a month.
Generic Availability:
There is no generic of the Envarsus XR formulation — patents run to 2028. Generic immediate-release tacrolimus and generic ER capsules exist, but the FDA label is explicit: Envarsus XR is not interchangeable or substitutable with any other tacrolimus product, so a pharmacist cannot swap it, and any change must be a physician-managed conversion with blood-level monitoring. Practically, that means affordability comes from the programs on this page, not from substitution — and any insurer pushing a switch should route through your transplant team, not the pharmacy counter.
Warnings:
Envarsus XR carries boxed warnings for increased infection risk and malignancy (including lymphoma and skin cancer — sun protection matters lifelong). It requires regular blood-level, kidney-function, glucose, and blood-pressure monitoring; tacrolimus can cause tremor, headache, kidney strain, elevated potassium, and new-onset diabetes after transplant. Interactions are extensive — azole antifungals, some antibiotics, and even grapefruit meaningfully change levels. Never adjust or stop dosing without your transplant team.
FAQ (Frequently Asked Questions)
How Much Does Envarsus XR Cost Without Insurance?
Cash prices run about $168 (0.75 mg), $221 (1 mg), and $860 (4 mg) per 30 tablets — and since daily doses often combine tablets, real monthly costs frequently exceed $1,000–$2,000. Eligible patients can receive Envarsus XR free through the Veloxis Transplant Support PAP; our $69.95 monthly fee covers full advocacy and enrollment management.
Can The Pharmacy Substitute Generic Tacrolimus For Envarsus XR
No — by FDA labeling, Envarsus XR is not interchangeable with immediate-release tacrolimus, ER capsules, or oral suspension. Any switch is a clinical conversion managed by your transplant team with blood-level monitoring. If cost pressure is pushing a switch, bring it to your team and to us — an assistance program usually solves it without touching the regimen.
Does Medicare Cover Envarsus XR?
Yes, with transplant-specific rules: if Medicare paid for your transplant, immunosuppressants bill under Part B — 20% coinsurance after the deductible, no $2,100 cap, so a Medigap supplement is what protects you. If your transplant wasn’t Medicare-covered, it bills under Part D, where the $2,100 cap (2026) does apply. Same drug, different math — we verify which side you’re on before any application.
What Is The Part B-ID Benefit?
Since 2023, kidney recipients under 65 who lose full Medicare 36 months after transplant can keep immunosuppressant-only Part B coverage indefinitely for a standalone premium — a lifeline that many eligible patients have never heard of. It covers anti-rejection drugs only, and isn’t available alongside Medicaid, VA, TRICARE, or private coverage. We screen every post-transplant Medicare patient for it.
Can I Use The $0 Copay Card With Medicare?
No — the card (up to $9,200/year) is commercial-insurance only. Medicare patients rely on Part B with a supplement, the Part D cap, Extra Help if income-qualified, or the Veloxis PAP — which, unusually, accepts federally underinsured patients.
What If My PAP Application Is Denied?
Denials are usually about documentation — missing income proof, an insurance-status mismatch, or incomplete transplant-team sections. Applications can be corrected and resubmitted, and for transplant drugs we treat resubmission as urgent by default. We review the denial letter, fix what triggered it, and resubmit on your behalf.
Take Control of Your Medication Costs
Generic tacrolimus IR dramatically cheaper than Envarsus XR. Check eligibility today.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.